Fidelity Investments’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76.8K Sell
16,238
-918
-5% -$5.6K ﹤0.01% 3914
2025
Q4
$310K Hold
17,156
﹤0.01% 3258
2025
Q3
$246K Hold
17,156
﹤0.01% 3276
2025
Q2
$132K Sell
17,156
-1
-0% -$7 ﹤0.01% 3482
2025
Q1
$102K Sell
17,157
-9,542
-36% -$83.3K ﹤0.01% 3548
2024
Q4
$355K Buy
26,699
+1,638
+7% +$17.3K ﹤0.01% 3045
2024
Q3
$204K Buy
25,061
+7,381
+42% +$63.2K ﹤0.01% 3189
2024
Q2
$150K Buy
17,680
+1,253
+8% +$18.8K ﹤0.01% 3145
2024
Q1
$285K Sell
16,427
-2,162
-12% -$38.4K ﹤0.01% 2905
2023
Q4
$238K Buy
18,589
+9,167
+97% +$214K ﹤0.01% 2909
2023
Q3
$349K Buy
9,422
+474
+5% +$21.1K ﹤0.01% 2726
2023
Q2
$360K Buy
8,948
+3,806
+74% +$215K ﹤0.01% 2764
2023
Q1
$373K Sell
5,142
-159
-3% -$15.4K ﹤0.01% 2791
2022
Q4
$435K Sell
5,301
-3,344
-39% -$348K ﹤0.01% 2758
2022
Q3
$817K Sell
8,645
-225,197
-96% -$25.3M ﹤0.01% 2657
2022
Q2
$45.5M Buy
233,842
+3,972
+2% +$648K ﹤0.01% 1306
2022
Q1
$53.4M Buy
229,870
+5,340
+2% +$1.7M ﹤0.01% 1365
2021
Q4
$88.5M Buy
224,530
+45,228
+25% +$19M 0.01% 1161
2021
Q3
$80.2M Buy
179,302
+121,791
+212% +$43.6M 0.01% 1198
2021
Q2
$22.4M Sell
57,511
-10,961
-16% -$3.91M ﹤0.01% 1806
2021
Q1
$24.6M Sell
68,472
-3,688
-5% -$1.63M ﹤0.01% 1718
2020
Q4
$35.4M Sell
72,160
-7,695
-10% -$3.55M ﹤0.01% 1466
2020
Q3
$25.9M Sell
79,855
-608
-0.8% -$207K ﹤0.01% 1460
2020
Q2
$29.3M Buy
80,463
+53,536
+199% +$13.5M ﹤0.01% 1393
2020
Q1
$5.73M Sell
26,927
-61
-0.2% -$19.4K ﹤0.01% 1885
2019
Q4
$11.1M Sell
26,988
-33,617
-55% -$11.6M ﹤0.01% 1810
2019
Q3
$21.4M Sell
60,605
-119,990
-66% -$44.8M ﹤0.01% 1550
2019
Q2
$90.8M Sell
180,595
-76,123
-30% -$53.7M 0.01% 952
2019
Q1
$255M Buy
256,718
+45,751
+22% +$42.5M 0.03% 556
2018
Q4
$183M Buy
210,967
+3,738
+2% +$3.47M 0.03% 628
2018
Q3
$214M Sell
207,229
-38,148
-16% -$37.3M 0.02% 648
2018
Q2
$225M Sell
245,377
-2,485
-1% -$2.67M 0.03% 612
2018
Q1
$242M Buy
247,862
+174,507
+238% +$159M 0.03% 611
2017
Q4
$33.2M Buy
73,355
+1,228
+2% +$453K ﹤0.01% 1486
2017
Q3
$29.8M Sell
72,127
-4,128
-5% -$1.56M ﹤0.01% 1548
2017
Q2
$26.7M Sell
76,255
-2,376
-3% -$915K ﹤0.01% 1557
2017
Q1
$40.4M Sell
78,631
-32,667
-29% -$13.5M 0.01% 1420
2016
Q4
$39.5M Sell
111,298
-30,078
-21% -$12.7M 0.01% 1406
2016
Q3
$75.6M Buy
141,376
+16,360
+13% +$8.88M 0.01% 1115
2016
Q2
$70.4M Buy
125,016
+28,812
+30% +$13.8M 0.01% 1127
2016
Q1
$45.8M Buy
96,204
+12,772
+15% +$5.75M 0.01% 1285
2015
Q4
$55.1M Buy
83,432
+19,269
+30% +$14.6M 0.01% 1222
2015
Q3
$50.4M Buy
64,163
+24,245
+61% +$29.6M 0.01% 1243
2015
Q2
$52.7M Buy
39,918
+12,165
+44% +$14M 0.01% 1317
2015
Q1
$28.8M Sell
27,753
-26,168
-49% -$17.3M ﹤0.01% 1592
2014
Q4
$36.1M Buy
+53,921
New +$32.9M ﹤0.01% 1481

Other funds holding ATRA